Christine Zedelmayer, Senior Vice President and Chief Operating Officer, on May 27, 2026, sold 95,833 shares in Equillium (EQ) for $267,209. Following the Form 4 filing with the SEC, Zedelmayer has control over a total of 62,586 common shares of the company, with 62,586 shares held directly.
SEC Filing:
Laura Alber, Director, President and Chief Executive Officer, on May 27, 2026, sold 15,000 shares in Williams Sonoma (WSM) for $3,000,000. Following the Form 4 filing with the SEC, Alber has control over a total of 957,424 common shares of the company, with 923,524 shares held directly and 33,900 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/719955/000071995526000138/xslF345X05/form4.xml
Joseph Douglas Lyon, Chief Accounting and Technology Officer, on May 27, 2026, sold 5,000 shares in Corcept Therapeutics (CORT) for $325,000. Following the Form 4 filing with the SEC, Lyon has control over a total of 6,230 common shares of the company, with 6,230 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1088856/000119312526248977/xslF345X05/ownership.xml
Paul Grewal, Chief Legal Officer, on May 27, 2026, sold 1,960 shares in Coinbase Global (COIN) for $346,683. Following the Form 4 filing with the SEC, Grewal has control over a total of 84,753 Class A common shares of the company, with 84,753 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1679788/000167978826000062/xslF345X05/wk-form4_1780092764.xml